327 related articles for article (PubMed ID: 11260973)
21. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.
Ferri S; Dal Pero F; Bortoletto G; Bianchi FB; Lenzi M; Alberti A; Gerotto M
J Viral Hepat; 2006 Mar; 13(3):166-76. PubMed ID: 16475992
[TBL] [Abstract][Full Text] [Related]
22. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?
De Vita S; Quartuccio L; Fabris M
Autoimmun Rev; 2008 Dec; 8(2):95-9. PubMed ID: 18589005
[TBL] [Abstract][Full Text] [Related]
24. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.
de Re V; Simula MP; Pavan A; Garziera M; Marin D; Dolcetti R; de Vita S; Sansonno D; Geremia S; Toffoli G
Ann N Y Acad Sci; 2009 Sep; 1173():152-60. PubMed ID: 19758144
[TBL] [Abstract][Full Text] [Related]
25. High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ.
Antonelli A; Ferri C; Ferrari SM; Ruffilli I; Colaci M; Frascerra S; Miccoli M; Franzoni F; Galetta F; Fallahi P
J Rheumatol; 2011 Sep; 38(9):1947-52. PubMed ID: 21724697
[TBL] [Abstract][Full Text] [Related]
26. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.
Saadoun D; Sellam J; Ghillani-Dalbin P; Crecel R; Piette JC; Cacoub P
Arch Intern Med; 2006 Oct; 166(19):2101-8. PubMed ID: 17060540
[TBL] [Abstract][Full Text] [Related]
27. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
28. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
29. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Kamar N; Ribes D; Izopet J; Rostaing L
Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
[TBL] [Abstract][Full Text] [Related]
30. HCV infection and extrahepatic manifestations.
Nocente R; Ceccanti M; Bertazzoni G; Cammarota G; Silveri NG; Gasbarrini G
Hepatogastroenterology; 2003; 50(52):1149-54. PubMed ID: 12846002
[TBL] [Abstract][Full Text] [Related]
31. Clonal CD27+ CD19+ B cell expansion through inhibition of FC gammaIIR in HCV(+) cryoglobulinemic patients.
De Re V; Pavan A; Sansonno S; Sansonno D; Racanelli V
Ann N Y Acad Sci; 2009 Sep; 1173():326-33. PubMed ID: 19758169
[TBL] [Abstract][Full Text] [Related]
32. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
Saadoun D; Bieche I; Authier FJ; Laurendeau I; Jambou F; Piette JC; Vidaud M; Maisonobe T; Cacoub P
Arthritis Rheum; 2007 Apr; 56(4):1315-24. PubMed ID: 17393409
[TBL] [Abstract][Full Text] [Related]
33. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.
Perotti M; Ghidoli N; Altara R; Diotti RA; Clementi N; De Marco D; Sassi M; Clementi M; Burioni R; Mancini N
Autoimmun Rev; 2008 Jun; 7(6):468-72. PubMed ID: 18558364
[TBL] [Abstract][Full Text] [Related]
35. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
36. B-lymphoproliferative disorders in patients with hepatitis C virus infection.
Pérez Sánchez I; Rivera Redondo J; García Monforte A; Mayoayo Crespo M; Escudero Soto A; Pintado Cros T
Haematologica; 1998 Oct; 83(10):946-8. PubMed ID: 9830804
[TBL] [Abstract][Full Text] [Related]
37. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens.
Simula MP; Caggiari L; Gloghini A; De Re V
Ann N Y Acad Sci; 2007 Sep; 1110():121-30. PubMed ID: 17911427
[TBL] [Abstract][Full Text] [Related]
38. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection.
La Civita L; Zignego AL; Lombardini F; Monti M; Longombardo G; Pasero G; Ferri C
J Rheumatol; 1996 Sep; 23(9):1641-3. PubMed ID: 8877939
[TBL] [Abstract][Full Text] [Related]
39. Cryoglobulinemia and progression of fibrosis in chronic HCV infection: cause or effect?
Siagris D; Christofidou M; Tsamandas A; Lekkou A; Thomopoulos K; Labropoulou-Karatza C
J Infect; 2004 Oct; 49(3):236-41. PubMed ID: 15337341
[TBL] [Abstract][Full Text] [Related]
40. [Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
Staak JO; Glossmann JP; Diehl V; Josting A
Med Klin (Munich); 2002 Oct; 97(10):601-8. PubMed ID: 12386793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
